CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,416 | -50.5% | 15,474 | -17.6% | 0.00% | -100.0% |
| Q1 2023 | $172,680 | -84.3% | 18,790 | -82.5% | 0.00% | -85.0% |
| Q4 2022 | $1,096,993 | +412.6% | 107,443 | +638.7% | 0.02% | +400.0% |
| Q3 2022 | $214,000 | -79.7% | 14,544 | -85.1% | 0.00% | -85.7% |
| Q1 2022 | $1,055,000 | -1.8% | 97,852 | +48.7% | 0.03% | -15.2% |
| Q4 2021 | $1,074,000 | +145.8% | 65,820 | +222.6% | 0.03% | +175.0% |
| Q3 2021 | $437,000 | – | 20,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |